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β-cateninSensory hair cells and supporting cells of the mammalian cochlea and vestibular (balance) organs exit the
cell cycle during embryogenesis and do not proliferate thereafter. Here, we have studied the mechanisms
underlying the maintenance of the postmitotic state and the proliferative capacity of these cells. We provide
the ﬁrst evidence of the role of cyclin D1 in cell cycle regulation in these cells. Cyclin D1 expression
disappeared from embryonic hair cells as differentiation started. The expression was transiently upregulated
in cochlear hair cells early postnatally, paralleling the spatiotemporal pattern of unscheduled cell cycle re-
entry of cochlear hair cells from the p19Ink4d/p21Cip1 compound mutant mice. Cyclin D1 misexpression in
vitro in neonatal vestibular HCs from these mutant mice triggered S-phase re-entry. Thus, cyclin D1
suppression is important for hair cell's quiescence, together with the maintained expression of cyclin-
dependent kinase inhibitors. In contrast to hair cells, cyclin D1 expression was maintained in supporting cells
when differentiation started. The expression continued during the neonatal period when supporting cells
have been shown to re-enter the cell cycle upon stimulation with exogenous mitogens. Thereafter, the steep
decline in supporting cell's proliferative activity paralleled with cyclin D1 downregulation. Thus, cyclin D1
critically contributes to the proliferative plasticity of supporting cells. These data suggest that targeted cyclin
D1 induction in supporting cells might be an avenue for proliferative regeneration in the inner ear.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe inner ear sensory epithelia, the organ of Corti of the cochlea
and the sensory epithelium of vestibular organs, comprise sensory
hair cells (HCs) and various types of supporting cells. Normal hearing
and balance functions depend on the generation and maintenance of
correct numbers of HCs. Also supporting cells are required for proper
inner ear function. Mammalian HCs and supporting cells are
postmitotic cells. Similar to many other types of terminally differen-
tiated cells, such as neurons, HCs do not divide even after trauma-
induced loss of neighboring cells. Mammalian supporting cells do not
normally proliferate, but mitogens can trigger their cell cycle re-entry
in vitro. This response is prominent during neonatal period and
declines signiﬁcantly thereafter (Montcouquiol and Corwin, 2001a,b;
White et al., 2006; Gu et al., 2007; Lu and Corwin, 2008). In contrast to
the inner ear sensory epithelial cells, some other types of differen-
tiated cells show a well-developed ability to produce daughter cells,
one example being hepatocytes whose robust proliferation following
injury underlies the distinct regenerative capacity of the liver
(reviewed in Fausto, 2000). Interestingly, in contrast to mammals,
inner ear supporting cells of non-mammalian species can divide andll rights reserved.generate progeny that transdifferentiates into functional HCs. These
events underlie the remarkable regenerative capacity of the inner ear
sensory cells of birds, ﬁshes and amphibians (Corwin and Cotanche,
1988; Ryals and Rubel, 1988).
Cyclin-dependent kinase inhibitors (Ckis), the negative cell cycle
regulators, are key regulators of the timing of cell cycle exit in
developing tissues. There are two Cki subfamilies, the Ink4 subfamily
consisting of p15Ink4a, p16Ink4b, p18Ink4c and p19Ink4d, and the Cip/Kip
subfamily consisting of p21Cip1, p27Kip1 and p57Kip2 polypeptides
(reviewed in Besson et al., 2008). HCs and supporting cells have
common precursors that exit the cell cycle during embryogenesis
(Ruben, 1967). Earlier studies have highlighted the importance of
p27Kip1 in this process (Chen and Segil, 1999; Lee et al., 2006). In
addition, p27Kip1 controls the nonproliferative status of differentiated
supporting cells (Löwenheim et al., 1999; White et al., 2006). The
maintenance of the postmitotic state of HCs is controlled by the Ckis
19Ink4d and p21Cip1 (Chen et al., 2003; Mantela et al., 2005; Laine et al.,
2007) and the prototypical member of the pocket protein family, the
retinoblastoma protein (pRb) (Mantela et al., 2005; Sage et al., 2005).
Despite the data on Ckis and pRb, the core cell cycle machinery in
the inner ear is to a large extent unexplored. Progression through the
cell cycle is governed by cyclin-dependent kinases (Cdks) that are
activated by binding to the regulatory subunits, the cyclins. Cyclin–
Cdk complexes phosphorylate (inactivate) pRb and other pocket
proteins (p107, p130), leading to E2F transcription factor-mediated
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inactivation is catalyzed by cyclin D–Cdk4 and cyclin D–Cdk6
complexes that trigger transition through the restriction point in
G1-phase and, thus, commitment to a new round of cell division.
Thereafter, full pRb inactivation is accomplished by cyclin E/A–Cdk2
complexes. The positive actions of cyclin–Cdk complexes are
countered by Ckis. Members of the Ink4 subfamily inhibit cyclin D–
Cdk4/6 complexes, while the Cip/Kip proteins can also inhibit cyclin
D–, E–, A– and B–Cdk holoenzymes. In addition, there is another level
of interaction between D-type cyclins and Cip/Kip inhibitors, in that
these cyclins can titrate Cip/Kip proteins from cyclin E/A–Cdk2
complexes and, thus, also by this function promote cell cycle
progression (reviewed in Besson et al., 2008).
The family of D-type cyclins is composed of cyclin D1 to D3 (cD1 to
D3) in mice. They are often expressed in mutually exclusive cell types
and developmental stages, but can also be expressed in overlapping
patterns. D-type cyclins have at least partly non-redundant functions,
as evidenced by developmental defects, albeit rather subtle, in mice in
which a single family member is inactivated. However, these defects
are exaggerated when 2 or 3 of these genes are simultaneously
disrupted. This fact together with the data that inactivation of a single
family member can cause compensatory upregulation of its relative
suggest for collaborative functions as well (Fantl et al., 1995; Sicinski
et al., 1995; Ciemerych et al., 2002). cD1 has broadest expression. In
addition that cD1 regulates cell proliferation under normal conditions,
its overexpression has been linked with the loss of cell cycle control in
tumors (Sicinski et al., 1995; Landis et al., 2006). D-type cyclins are
induced by mitogens and their levels decrease when mitogens are
removed or when anti-mitogenic factors are added (Matsushime et
al., 1991). Thus, D-cyclins serve as a link between the extracellular
environment and the core cell cycle machinery.
It has been shown in the p19Ink4d single knock-out and more
prominently in the p19Ink4d/p21Cip1 double knock-out (dko) mice that
postnatal cochlear HCs abnormally re-enter the cell cycle (Chen et al.,
2003; Laine et al., 2007). Analysis of these dko mice showed that cell
cycle reactivation is initiated in the upper basal part of the cochlea at
P3 and that it peaks at P7, when high numbers of proliferating HCs are
found in the upper basal and middle parts of the cochlea. Thereafter,
cell cycle re-entry abruptly decreases, so that of the 2 cochlear HC
subtypes—the inner hair cells (IHCs) and outer hair cells (OHCs)—only
a small number of IHCs and very fewOHCs are proliferating at P10 and
thereafter (Laine et al., 2007). Importantly, unscheduled proliferation
of cochlear HCs from the p19Ink4d single mutant and p19Ink4d/p21Cip1
dko mice resulted in the death of these cells (Chen et al., 2003; Laine
et al., 2007). In contrast to cochlear HCs, p19Ink4d/p21Cip1 inactivation
did not trigger cell cycle reactivation of vestibular HCs (Laine et al.,
2007). Inspired by this spatiotemporally very distinct pattern of cell
cycle re-entry, we aimed to identify additional factors that regulate
the maintenance of the postmitotic state of HCs and their proliferative
capacity. We provide here evidence of the role of cD1. These results
are likely to be important for the ﬁeld of therapeutic HC regeneration
and for understanding the regulation of the postmitotic state of
differentiated cells.
Materials and methods
Mice
p19Ink4d/p21Cip1 dko mice were generated and genotyped by PCR
using tail DNA extracts, as previously described (Laine et al., 2007).
Control NMRI mice were used for mRNA and protein expression
analyses. The BAT-gal reporter mice (Maretto et al., 2003) were used
to study the activity of canonical Wnt/β-catenin signaling. Genotyp-
ing was done as described by Maretto et al. (2003). For timed
pregnancies, the morning of vaginal plug identiﬁcation was taken asembryonic day 0.5 (E0.5) and the day of birth as postnatal day 0 (P0).
Animal care was in accordance with institutional guidelines.
Tissue preparation and immunohistochemistry on sections
Inner ears at E13.5, E15.5, E16.5, P0, P2, P3, P4, P7, P10, P15 and
P60 were analyzed. Dissected inner ears were ﬁxed overnight in 4%
paraformaldehyde (PFA) in PBS. Inner ears from P3 and older mice
were decalciﬁed in 0.5 M EDTA, pH 8.0, followed by embedding in
parafﬁn and cutting to 5-μm-thick sections. Epitopes were unmasked
by microwave heating (800 W) in 10 mM citrate buffer, pH 6.0, for
10 min. An overnight incubation was performed with the following
primary antibodies: rabbit polyclonal myosin 7a (Hasson et al., 1997);
rabbit monoclonal cD1, mousemonoclonal cD2, rabbit monoclonal Ki-
67, mouse monoclonal p27Kip1 (LabVision/Thermo Scientiﬁc); and
goat polyclonal p57Kip2 (Santa Cruz Biotechnology). Detection was
done with Vectastain Elite ABC kit or Vectastain Mouse-On-Mouse kit,
and diaminobenzidine substrate (Vector Laboratories). Sections were
counterstained with 2% methyl green and mounted in Permount
(Fisher Scientiﬁc). In double-labeling experiments, myosin 7a staining
was detected by immunoﬂuorescence using Alexa 568-coupled
secondary antibodies (Molecular Probes/Invitrogen) and thereafter
p27Kip1 was reacted as described above. Vectashield (Vector Labora-
tories) was used for mounting. In Ki-67/p27Kip1 double-immunoﬂu-
orescence, Alexa 568- and Alexa 488-coupled secondary antibodies
were used. Analysis was done with a BX61 microscope (Olympus)
using bright- and dark-ﬁeld and Nomarski optics and epiﬂuorescence.
Images were acquired through CCD camera (DP70) and analySIS
software (Olympus), and processed using Adobe Photoshop CS2
(Adobe Systems).
In situ hybridization
In situ hybridization was performed with riboprobes labeled with
35S-UTP andwith PFA-ﬁxed, parafﬁn-embedded sections, as described
(Wilkinson and Green, 1991). Inner ears at P0, P2, P3, P7, P10, P15 and
P60 were analyzed for p15Ink4a, p16Ink4d, p18Ink4c, p21Cip1 and p57Kip2
expressions. p19Ink4d and cD1 expressions were studied at these
stages as well as at E13.5, E15.5, E16.5 and P4. Sections were
counterstained with hematoxylin. Images were processed using
Adobe Photoshop CS2. Autoradiographic silver grains in the dark
ﬁeld image were selected, colored red and superimposed onto the
brightﬁeld image.
Cochlear wholemounts
Cochlear ducts were dissected from p19Ink4d/p21Cip1 dko and
controlmice at P7. Lateral wall and tectorial membranewere removed
and specimens were ﬁxed with PFA overnight. Wholemounts were
incubated overnight with antibodies against cD1, myosin 7a or Ki-67,
followed by incubation with Alexa 488- and Alexa 568-coupled
secondary antibodies, and mounting in Vectashield. Images were
acquired with a TSC SP5 confocal microscope using HCX PL APO 20×/
0.7 (glycerol) and HC PL Fluotar 5×/0.15 (air) objectives (Leica).
Three-dimensional image stacks were processed and analyzed using
the Imaris 5.7.1 software (Bitplane).
Utricular explants infected with adenoviruses
Organotypic cultures of the utricular sensory epithelium were
prepared from the p19Ink4d/p21Cip1 dko mice and wildtype littermates
at P5. Explants were maintained on pieces of Nuclepore ﬁlter
membrane (Whatman) in DMEM/F-12 medium supplied with
2 mM L-glutamine, penicillin (100 U/ml) (Gibco/Invitrogen) and
10% fetal bovine serum (HyClone/Thermo Scientiﬁc). Incubations
were done in a humidiﬁed 5% CO2 atmosphere at 37 °C. The adenoviral
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expressed under the CMV promoter. Cloning and propagation of
recombinant adenoviruses of serotype 5 have been described
previously (Albrecht and Hansen, 1999). Prior to infection, dissected
utricular explants were stabilized on ﬁlters for 12 h. Infections were
done in serum-free medium at the titers of 1.97×107 pfu/ml for
AdcD1 and 1.93×107 pfu/ml for AdLacZ for 6 to 8 h in a volume of
25 μl. Thereafter, explants were maintained in serum-containing
medium for 66 h. Explants were ﬁxed with PFA for 15 min. Double- or
triple-immunoﬂuorescence was performed using antibodies against
cD1, goat polyclonal Jagged 1 (Santa Cruz Biotechnology), mouse
monoclonal Ki-67 (Novocastra), goat polyclonal parvalbumin (Swant)
andmousemonoclonal β-galactosidase (β-gal) (Promega). Secondary
antibodies conjugated to Alexa 350, Alexa 488 and Alexa 594 were
used for visualization and ProLong® Gold anti-fade reagent (Molec-
ular Probes/Invitrogen) for mounting.
For quantiﬁcation of viral infection efﬁciency in AdLacZ-infected
utricular explants from control mice, numbers of β-gal+/parvalbu-
min+ HCs were counted. For quantiﬁcation of induction of prolifer-
ation in AdcD1-infected explants from the p19Ink4d/p21Cip1 dko mice,
Ki-67+/cD1+/parvalbumin+ HCs were counted. Three to 5 random
20× microscopic ﬁelds were analyzed per explant.
Cochlear explants treated with BIO
Cochlear explants from P0 control mice were treated with the
glycogen synthase kinase-3 (GSK-3) inhibitor BIO (6-bromoindiru-
bin-3′-oxime; Calbiochem). BIO was dissolved in dimethyl sulfoxide
(DMSO; Sigma-Aldrich) and used at the concentration of 5 μM.
Explants were stabilized for 2 h on ﬁlters in the medium described
above and thereafter changed to medium containing BIO. DMSO
concentration in the medium was 0.05%, also in parallel control
cultures. Cultures were maintained for 48 h and thereafter ﬁxed with
PFA and double-stained for cD1 and parvalbumin or Ki-67 and
parvalbumin. Alexa 488 and Alexa 594 secondary antibodies were
used for detection. Confocal imageswere obtained as described above.
A part of explants was processed for parafﬁn sections that were
stained with the mouse monoclonal β-catenin (BD Biosciences) or
myosin 7a antibodies. Detectionwas donewith the VectastainMouse-
On-Mouse kit or the Vectastain Elite ABC kit. Diaminobenzidine
substrate was used for detection.
β-Galactosidase staining
Inner ears were dissected from BAT-gal mice at E16.5, P0, P7 and
P10. The mesenchymal/bony capsule was removed and the cochleo-
vestibular labyrinth was ﬁxed for 30 min in PFA. Specimens were
incubated in X-gal staining solution [1 mg/ml X-gal (Promega), 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.025% sodium deoxycho-
late and 0.025% Nonidet P-40] overnight at room temperature and
thereafter prepared for parafﬁn sections. They were counterstained
with 0.1% nuclear fast red or stained with antibodies against myosin
7a, Ki-67 or cD1.
Results
Cki expressions in the cochlea and vestibular organs
We ﬁrst studied the expression of all known Ckis in the inner ear
sensory epithelia of normal mice, using radioactive in situ hybridiza-
tion and immunohistochemistry on parafﬁn sections. p19Ink4d has
been earlier localized to the organ of Corti of the late-embryonic
cochlea (Chen et al., 2003). Consistent with these data, we found that
p19Ink4d starts to be expressed in cochlear HCs at E15.5, at the stage
whenmorphological differentiation of these cells is initiated (data not
shown). Between P0 and P10, p19Ink4d was found both in IHCs andOHCs at all levels of the cochlea (Figs. 1a, b). Thereafter, the
expression gradually decreased in OHCs, while prominent signal
was maintained in IHCs, as analyzed at P15 and P60 (data not shown).
HCs of the vestibular organs—utricle, saccule and ampullae—showed
strong p19Ink4d expression during early postnatal life (Fig. 1c). This
expression was maintained at a modest level during adulthood (data
not shown). Inner ear supporting cells did not express p19Ink4d (Figs.
1a–c). As studied by in situ hybridization, expressions of the other
members of the Ink4 family—p15Ink4a, p16Ink4b and p18Ink4c (Fig. 1d;
data not shown)—were not detected in the inner ear sensory epithelia
at any stage. p18Ink4c was localized to the mesenchymal compartment
of the inner ear (Fig. 1d).
p21Cip1 has earlier been localized to the developing inner ear
sensory epithelia (Mantela et al., 2005; Laine et al., 2007). As assessed
by in situ hybridization, p21Cip1was broadly expressed in the inner ear
during the postnatal maturation period. It was found both in IHCs and
OHCs and in supporting cells of the organ of Corti (Fig. 1e). Thereafter,
the signal was downregulated to low levels, so that at P60, only
Deiter's cells showed expression that was very weak (data not
shown). Similar to the organ of Corti, low-level expression of p21Cip1
was detected in the vestibular sensory epithelia (Fig. 1f).
p27Kip1 is known to be expressed in supporting cells of the
embryonic and postnatal inner ear sensory epithelia (Chen and Segil,
1999; Löwenheim et al., 1999; Lee et al., 2006; White et al., 2006). In
the current study, we used immunochemistry and aimed for revealing
the lowest levels of p27Kip1 during postnatal life. p27Kip1 was
prominently expressed in different types of cochlear supporting
cells from birth until adulthood, with the exception of Deiter's cells
(Figs. 2a–c). These supporting cell types were strongly stained
between P0 and P10 (Figs. 2a, b), but thereafter the expression was
gradually downregulated, so that only weak expression remained at
P60 (Fig. 2c). We have earlier detected low-level expression of p27Kip1
by quantitative PCR in HCs dissociated from the cochlea at P7 (Laine et
al., 2007). However, we could not detect p27Kip1 protein in cochlear
HCs at this stage or at later stages of life (Fig. 2c), possibly because the
protein levels are below the detection limit of immunohistochemistry
or because p27Kip1 transcripts are not translated into protein.
Supporting cells of the vestibular organs expressed p27Kip1
throughout postnatal life (Figs. 2d–f′), although this expression was
not as strong as in cochlear supporting cells. Around birth, low-level
proliferative activity was still found in the utricular sensory
epithelium, as revealed by Ki-67 staining (Figs. 2d, e). Ki-67 marks
cells in late G1-, S-, G2- and M-phases of the cell cycle. As seen in
adjacent sections, p27Kip1 staining was strongest in the areas lacking
Ki-67 labeling (Figs. 2d, e). This result was conﬁrmed by double-
immunoﬂuorescence with p27Kip1 and Ki-67 antibodies (inset in Fig.
2e). These data are consistent with the role of p27Kip1 as a negative
cell cycle regulator. In contrast to cochlear HCs, a small part of HCs
located in a scattered manner within the utricular sensory epithelium
showedweak p27Kip1 expression, both at early postnatal stages and at
adulthood. These observations were conﬁrmed by double-labeling
experiments with antibodies against p27Kip1 and myosin 7a, a HC
marker (inset in Figs. 2f, f′).
p57Kip2, the third member of the Cip/Kip subfamily of Ckis, is also
known to be expressed in the developing inner ear sensory epithelia
(Laine et al., 2007; Kirjavainen et al., 2008). In the cochlea at P0,
p57Kip2 was localized to OHCs as well as to the nonsensory epithelium
of inner sulcus (Fig. 2g). In addition, a small part of IHCs showedweak
expression (data not shown). p57Kip2 was still expressed in HCs at P2,
but not anymore at P3 or thereafter (Fig. 2h). Cochlear supporting
cells did not express p57Kip2 at any stage. Similarly, in the utricular
sensory epithelium between P0 and P60, the supporting cell layer
lacked 57Kip2 staining, while, interestingly, a small number of cells at
the level of the HC layer showed expression (Fig. 2i). These expression
patterns were conﬁrmed by in situ hybridization at the mRNA level
(data not shown).
Fig. 1. Expression of cyclin-dependent kinases in the postnatal inner ear, as revealed by in situ hybridization. (a) At P2, p19Ink4d is expressed in the organ of Corti at all levels of the
cochlea and in the cochlear ganglion neurons. (b) Higher magniﬁcation shows p19Ink4d expression at P7 in cochlear HCs, but not in supporting cells. (c) At P7, p19Ink4d is found in HCs
of the utricle. Underlying supporting cells do not show expression. (d) At P2, p18Ink4c is not expressed in the inner ear epithelium, as shown for the utricle, but is found in the
mesenchyme. (e) At P2, p21Cip1 is broadly expressed in the cochlea, including the organ of Corti, nonsensory epithelial regions and mesenchymal regions, such as the spiral limbus,
and in the cochlear ganglion. (f) At P7, p21Cip1 is expressed in the utricular sensory epithelium and in the mesenchyme where the signal is strong. Abbreviations: co, cochlea; ut,
utricle; OHCs, outer hair cells; IHC, inner hair cell; CG, cochlear ganglion; HCs, hair cells; SCs, supporting cells; SV, stria vascularis; RM, Reisner's membrane; SL, spiral limbus. Scale
bar: 150 μm for panels a and e; 120 μm for panels c, d and f; 60 μm for panel b.
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inner ear HCs from the p19Ink4d/p21Cip1 dko mice to re-enter the cell
cycle (Laine et al., 2007) cannot be fully explained by Cki expression
patterns. Most strikingly, p19Ink4d and p21Cip1 are expressed both in
cochlear and vestibular HCs, but their codeletion leads to cell cycle
reactivation in cochlear HCs only. Furthermore, Cki expressions in HCs
are relatively homogenous along the length of the cochlear duct and,
thus, are not consistent with the spatially restricted pattern of
abnormal cochlear HC proliferation seen in the dko mice (Laine et al.,
2007).
Transient cyclin D1 expression corresponds to the pattern of
unscheduled cochlear HC proliferation in the p19Ink4d/p21Cip1 dko mice
We studied whether D-type cyclins contribute to the pattern of
aberrant proliferation of cochlear HCs from the p19Ink4d/p21Cip1 dkomice. cD1 and cD2 expressions were analyzed by immunochemistry.
In addition, in situ hybridization for cD1was performed. Wholemount
cochlear specimens from control mice at P7 were stained for myosin
7a to mark the 4 rows of HCs (Fig. 3a). As expected, normal HCs did
not show Ki-67 staining (Fig. 3b). cD1 was expressed in HCs located in
the upper basal andmiddle parts of control cochleas. This stainingwas
much stronger in supporting cells situated on both sides of the organ
of Corti (Fig. 3c). In line with previous data (Laine et al., 2007), the dko
mice at P7 showed unscheduled HC proliferation in the upper basal
andmiddle regions of the cochlea, based onKi-67 staining (Figs. 3d–g).
Thus, the pattern of abnormal HC proliferation along the length of the
cochlear duct from the dko mice corresponds to the pattern of cD1
expression. Cochleas from the dko mice showed comparable cD1
expression as control cochleas, although a part of HCs had been lost as
a result of abrnormal cell cycle re-entry, as earlier described (Figs.
3h–j; Laine et al., 2007).
Fig. 2. Expression of p27Kip1 and p57Kip2 in the postnatal inner ear, as revealed by immunochemistry. (a, b) At P2, p27Kip1 is strongly expressed in supporting cells of both the upper
middle (a) and upper basal (b) turns of the cochlea, and in the cochlear ganglion neurons. The supporting cell types lying underneath hair cells, the Deiter's cells, are marked. Hair
cells do not show expression. (c) At P60, several cochlear supporting cells types show strong p27Kip1 expression, except for Deiter's cells in which only very weak staining is detected.
Hair cells are negative for p27Kip1. (d, e) As shown in adjacent sections at P0, p27Kip1 is expressed in supporting cells of the utricle and ampulla. The area of the utricular
sensory epithelium where this staining is most prominent is devoid of Ki-67 staining (arrows), as also shown in inset by p27Kip1/Ki-67 double-immunoﬂuorescence. Note also
weak p27Kip1 expression in some HCs. (f, f′) Double-staining shows that p27Kip1 (f; immunoperoxidase staining without counterstaining) is expressed in a part of myosin 7a-
positive (f′; immunoﬂuorescence) utricular hair cells. The layer of supporting cell nuclei is indicated. Arrows mark examples of double-labeled hair cells. (g) At P0, p57Kip2 is
distinctly expressed in outer hair cells and inner sulcus of the cochlea. (h) At P7, p57Kip2 is not anymore detected in these cochlear regions. (i) At P7 in the utricle, a scattered
population of cells at the bottom of the hair cell layer show p57Kip2 expression. Abbreviations: co, cochlea; ut, utricle; IHC, inner hair cell; OHCs, outer hair cells; D, Deiter’s cell;
amp, ampulla; myo7a, myosin 7a; CG, cochlear ganglion; IS, inner sulcus. Scale bar: 120 μm for panels a, b, d, e, and i; 80 μm for panels c, f, f′, g, and h.
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lacked cD1 mRNA (Fig. 4a) and protein (Fig. 4b) expression at P1.
cD1 was transiently upregulated in cochlear HCs during early
postnatal life. This upregulation was ﬁrst seen in the upper basal
part of the cochlea at P2, very weakly at this stage (data not
shown). By P3, staining intensity in this location had increased, but
HCs in the middle and apical parts were negative (Figs. 4c, d). By
P4, cD1 expression had expanded into the middle part of the
cochlea, but the apical part remained negative (Figs. 4e, f). At P7,
cD1 was localized to IHCs and OHCs of the upper basal and middle
regions of the cochlea (Fig. 4g). Thereafter, the expression wasdownregulated, so that several IHCs, but only a few OHCs were
positive at P10 (Fig. 4h). At P15 (Fig. 4i) and thereafter, cD1 was
undetectable in cochlear HCs. This dynamic cD1 expression was
conﬁrmed by in situ hybridization (data not shown). These data
together with our results on wholemount specimens show that
transient cD1 expression in cochlear HCs precisely corresponds to
the pattern of abnormal HC proliferation seen in the p19Ink4d/
p21Cip1 dko mice.
Several types of cochlear supporting cells showed strong cD1
staining during the ﬁrst 10 days after birth, with the exception of
Deiter's cells (Figs. 4a–h). cD1 expression rapidly declined thereafter
Fig. 3. Expression of cyclin D1 and Ki-67 in cochlear wholemounts from control and p19Ink4d/p21Cip1 double mutant mice at P7. (a, b) In control specimens, myosin 7a-positive hair
cells, arranged in 4 rows, do not express Ki-67. (c) Hair cells from the middle part of the cochlea are weakly stained for cyclin D1. Surrounding supporting cells show strong
expression. (d) A view of the whole cochlear duct from a double mutant mouse shows Ki-67-positive hair cells in the upper basal and middle parts of the cochlea. (e–g) Boxed areas
in panel d are shown in higher magniﬁcations. Dotted lines mark the HC region. Ki-67 labeling is seen in the upper basal and middle, but not in apical regions of cochleas from the
mutant mice. (h–j) In the mutant mice, the distribution of cyclin D1-positive hair cells along the length of the cochlear duct corresponds to the pattern of Ki-67 labeling. Note the
uneven cD1 staining in the cochlear middle region, due to the death of cell cycle reactivated hair cells. Abbreviations: HCs, hair cells; dko, p19Ink4d/p21Cip1 double mutant mice; cD1,
cyclin D1; myo7a, myosin 7a. Scale bar: 50 μm for panels a–c an e–j; 200 μm for panel d.
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were stained at adulthood (data not shown).
Vestibular HCs from the p19Ink4d/p21Cip1 dko mice do not re-
enter the cell cycle at any age, in contrast to cochlear HCs (Laine et
al., 2007). We analyzed cD1 expression in the sensory epithelium of
the normal utricle, using it as a model for the 3 different types of
vestibular organs. At birth, utricular HCs lacked cD1 staining (Fig.
4j). Main part of these cells remained negative during postnatal life,
consistent with their nonproliferative status in the dko mice.
Interestingly, a small number of cells that based on their location
were HCs showed cD1 expression at early postnatal and adult
stages (Figs. 4k, l). Utricular supporting cell population was
homogenously stained for cD1 at birth (Fig. 4j). Thereafter, cD1
progressively disappeared from a part of these cells, as already seen
at P2 (data not shown) and clearly at P7 (Fig. 4k). A small group of
utricular supporting cells maintained cD1 expression at adulthood
(Fig. 4l).Cyclin D1 overexpression elicits cell cycle reactivation in utricular HCs
from the p19Ink4d/p21Cip1 dko mice
Next, we directly addressed the hypothesis that cD1 expression
underlies the pattern of unscheduled HC proliferation in the
p19Ink4d/p21Cip1 dko mice. Utricular explants were prepared at P5,
cD1 was misexpressed in HCs using adenoviral-mediated gene
transfer, and cultures were maintained for 3 days. Based on
expression data in vivo (Figs. 4j, k), we ﬁrst double-labeled utricular
wholemount specimens with antibodies against cD1 and the HC
marker parvalbumin or against cD1 and the supporting cell marker
Jagged 1. In these experiments, we conﬁrmed that the main part of
utricular HCs lacked endogenous cD1 expression in vitro (Fig. 5a). In
contrast, supporting cells situated underneath HCs showed this
expression (Fig. 5a). Adenoviruses with the LacZ transgene (AdLacZ)
were used to study infection efﬁciency into utricular HCs. Utricular
explants stained for β-galactosidase and parvalbumin showed that
Fig. 4. Expression of cyclin D1 in the postnatal inner ear sensory epithelia, as revealed by in situ hybridization (a) and immunohistochemistry (b–l). A part of views (c, f) is ﬂipped so
that all cochlear cross-sections are displayed in the same orientation. (a, b) At P1, cyclin D1 mRNA and protein are not expressed in hair cells or Deiter's cells of the organ of Corti, in
contrast to other types of supporting cells. (c–h) Cyclin D1 is transiently upregulated in cochlear hair cells during the ﬁrst 2 postnatal weeks. This upregulation starts from the upper
basal part of the cochlear duct at P3 and spreads into the middle part, but does not extend into the apex of the cochlea. See text for more details. (i) At P15, cyclin D1 is not anymore
expressed in hair cells, but is seen in a few laterally located supporting cells (arrowhead). (j) At P0 in the utricle and ampulla, the majority of hair cells lack cyclin D1 expression. In
contrast, prominent and homogenous expression is found in the supporting cell population. (k, l) At P7 (k) and P60 (l), cyclin D1 expresssion is maintained in a small part of
supporting cells. In addition, a few hair cells seem to express it (arrows). Abbreviations: co, cochlea; ut, utricle; cD1, cyclin D1; IHC, inner hair cell; OHCs, outer hair cells; I,
interphalangeal cell; P, pillar cell; D, Deiter's cell; H, Hensen's cell; C, Claudius cell; amp, ampulla. Scale bar: 120 μm for panels a, j–l; 40 μm for panels b–i.
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Fig. 5. Cyclin D1 misexpression triggers cell cycle reactivation in utricular hair cells from the p19Ink4d/p21Cip1 double mutant mice. Utricular explants were infected with AdLacZ or
AdcD1 at P5, and maintained for 3 DIV. Immunoﬂuorescence was applied on wholemount specimens. (a) Endogenous cyclinD1 is not found in parvalbumin-positive hair cells of
utricular explants maintained for 3 DIV, as shown by double-staining. Supporting cells located underneath hair cells express cyclin D1. Inset in panel a shows cD1 expression (red) in
Jagged 1-positive (green) utricular supporting cells. (b–b″′) Wildtype explants infected with AdLacZ show after triple-labeling that a part of parvalbumin-positive hair cells express
β-galactosidase and that these cells are negative for Ki-67. (c–d′) Based on double-staining for parvalbumin and Ki-67, AdcD1-infected explants from wildtype mice do not show
proliferating HCs, in contrast to these explants from the double mutant mice. The highmagniﬁcation inset in panel c′ shows that, in a wildtype specimen, Ki-67 labeling is conﬁned to
parvalbumin-negative supporting cells located underneath the hair cell layer. The high magniﬁcation inset in panel d′ shows, in a double mutant specimen, Ki-67 staining in
parvalbumin-positive hair cells. (e–f″′) Triple-staining for parvalbumin, cyclin D1 and Ki-67 shows that hair cells overexpressing cyclin D1 (arrowheads) coexpress the proliferation
marker in the mutant, but not wildtype specimens. See text for details. Abbreviations: pa, parvalbumin; β-gal, β-galactosidase; cD1, cyclin D1; DKO, p19Ink4d/p21Cip1 double mutant
mice; WT, wildtype. Scale bar: 70 μm for panels a and c–d′; 150 μm for panels b–b″′; 25 μm for panels e–f″′.
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explants counted) (Figs. 5b–b″). Triple-labeling revealed that HCs in
these explants were negative for Ki-67 (Figs. 5b–b″′). Next, utricular
explants from wildtype and p19Ink4d/p21Cip1 dko mice were infected
with AdcD1. It resulted in the appearance of Ki-67+ HCs in explants
from dko, but not from wildtype mice (Figs. 5c–d′). Quantiﬁcation
revealed that 17% of HCs were Ki-67-positive in AdcD1-infected
utricles from dko animals (a total of 1942 parvalbumin+ HCs in
8 explants transduced by AdcD1 counted, SD=9.7, pb0.01). Triple-
staining conﬁrmed the presence of cD1 in parvalbumin-expressing
HCs of both genotypes, but the transgene induced Ki-67 expression
only in HCs of dko specimens (Figs. 5e–f″′). In the mutant cultures,
in addition to the presence of cD1+/Ki-67+ HCs, a part of
proliferating HCs showed hardly detectable cD1 staining (Figs.
5f–f″′). This is consistent with the knowledge that cD1 expression
predominates in late G1 and that its levels considerably decrease
in S-phase (Baldin et al., 1993). Taken together, cD1 overexpression
can trigger cell cycle re-entry in the absence of Ckis, suggesting that
the maintenance of the postmitotic state of HCs requires tight control
of the expression of both the positive and negative cell cycle
regulators.Cyclin D1 expression in the inner ear sensory epithelia during
embryogenesis
We next studied the link between proliferative activity and cD1
expression in the inner ear sensory epithelia during embryogenesis.
In the mouse cochlea, precursor cells common for HCs and
supporting cells exit the cell cycle between E12 and E14 (Ruben,
1967), and subsequently start with cell type-speciﬁc differentiation
program. cD1 was widely expressed in the cochlear duct epithelium
at E13.5, including the region of the presumptive organ of Corti (Fig.
6a). In the upper part of the nascent cochlear duct, this region
lacked Ki-67+ cells (Fig. 6b), demonstrating that cells had exited
the cell cycle, in line with earlier data (Chen and Segil, 1999; Lee et
al., 2006). Thus, cD1 expression is maintained in precursor cells
after terminal mitoses. Widespread cD1 expression was maintained
in the cochlear duct until E15.5 when morphological differentiation
of sensory epithelial cells was initiated. Onset of HC differentiation
was associated with cD1 downregulation, as shown at E16.5 (Figs.
6c–e). The ﬁrst emerging IHCs lacked cD1 expression and the
staining intensity was clearly decreased in OHCs whose differenti-
ation shortly follows that of IHCs (Figs. 6d, e). cD1 downregulation
Fig. 6. Cyclin D1 and cyclin D2 expression in the embryonic inner ear, as revealed by immunohistochemistry. Methyl green counterstaining. (a, b) As shown in adjacent sections at
E13.5, cyclin D1 is broadly expressed in the cochlear epithelium, including the prosensory domain that lacks Ki-67 staining (arrow). (c, d) By E16.5, cyclin D1 is downregulated in
differentiated hair cells of the basal part of cochlea. The undifferentiated apical part of the cochlea does not show this downregulation. (e) Higher magniﬁcation of the boxed area in
panel d shows cyclin D1 downregulation in hair cells and also the initiation of this downregulation in Deiter's cells. (f, g) As shown in adjacent sections at E13.5, cyclin D1 and Ki-67
are broadly expressed in the vestibular epithelia. (h, i) By E16.5, cyclin D1 expression has disappeared from the majority of differentiated utricular hair cells, while strong expression
persists in supporting cells. An adjacent section shows modest proliferative activity in this epithelium. (j–m) Using the lens at E13.5 as a positive control for the cyclin D2 antibody
(transition zone cells marked by arrowheads in j), this staining is not found in the cochlear sensory epithelium at E13.5 (k) or P7 (l), or in the utricle at P7 (m). Abbreviations: co,
cochlea; ut, utricle; amp, ampulla; cD1, cyclin D1; cD2, cyclin D2; D, Deiter's cell; IHC, inner hair cell; OHCs, outerhair cells. Scale bar: 100 μm for panels a–d and f–i; 30 μm for panel e;
150 μm for panels j–m.
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the well-known gradient of HC differentiation (reviewed in Kelley,
2006). cD1 suppression reached HCs in the apical region of the
cochlea by P1 (data not shown). The different types of cochlear
supporting cells expressed cD1 during late-embryogenesis, exceptfor Deiter's cells in which the expression was downregulated in a
base-to-apex gradient, similarly as in HCs (Fig. 6e).
Similarly as in the cochlea, cD1 was broadly expressed in the
early-developing vestibular organs (Figs. 6f, h). Vestibular HC
differentiation, of which initial signs were seen at E13.5, was
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expression was maintained throughout the population of differen-
tiating supporting cells, as shown in the utricle at E16.5 (Fig. 6h). At
both stages analyzed, cD1 expression in vestibular organs did not
correlate with the distribution of Ki-67+ cells (Figs. 6f–i). Using theFig. 7. Localization of activated Wnt/β-catenin signaling in the inner ear in vivo, as show
upregulation in neonatal cochlear hair cells in vitro. Nuclear fast red (a, c) and methyl green
from a BAT-gal reporter mouse at E16.5 shows only little β-catenin activity in the epithelium
mice at P7 do not show X-gal staining, as seen under Nomarski optics. Modest transgene ac
sensory epithelium and vestibular nonsensory epithelium show strong X-gal staining, while
and Ki-67 shows no correlation between BAT-gal expression and proliferative activity in the u
gal activity and cyclin D1 expression in the utricle at P7, as shown under Nomarski optics
translocation to the cell nuclei, including hair cell nuclei (arrows). This is not seen in contro
cultures. (j) In control explants, cyclin D1 is prominenty expressed in supporting cells. The ne
of the 4 hair cell rows is seen in BIO-treated explants. (l, l′) BIO treatment does not trigger cy
cochlea. Double-labeling shows the absence of Ki-67 induction in the organ of Corti. Dotted
ampulla; ve, vestibular organs; CG, cochlear ganglion; cD1, cyclin D1; myo7a, myosin 7a; β-ca
120 μm for panels b, c, and e; 80 μm for panel d; 50 μm for panels f–l′.anterior epithelial layer and transition zone cells of the lens at E13.5
(Rowan et al., 2008) as positive control cells for cD2 expression (Fig.
6j), the cochlear duct and vestibular sensory epithelia were not
labeled with the cD2 antibody, neither during embryogenesis nor
postnatally (Figs. 6k–m).n in the BAT-gal reporter mice. The GSK-3 inhibitor BIO does not trigger cyclin D1
(g, i) counterstainings or no counterstaining (b, d, e, f, h). (a) An X-gal stained cochlea
(arrors mark the organ of Corti). (b) Myosin 7a-positive cochlear hair cells from BAT-gal
tivity is seen in the neuronal compartment of the inner ear. (c) At E16.5, the ampullary
it is more restricted in the utricular sensory epithelium. (d) Double-staining for X-gal
tricle at E16.5. (e) Double-staining reveals that correlation is also lacking between BAT-
. (f–i) β-catenin-stained sections through BIO-treated cochlear explants show protein
l specimens. Adjacent, myosin 7a-stained sections show hair cell preservation in these
gative hair cell area in the middle part of the cochlea is marked. (k) Normal appearance
clin D1 upregulation in the hair cell area, as shown in a view from the middle part of the
line in panel l′ marks the hair cell region. Abbreviations: co, cochlea; ut, utricle; amp,
t, β-catenin; pa, parvalbumin; ns, nonsensory epithelium. Scale bar: 200 μm for panel a;
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The distinct spatiotemporal pattern of cD1 expression in the inner
ear sensory epithelia raised the question of its regulation. cD1 has
been shown to be one of the many targets of the canonical Wnt/β-
catenin pathway (Tetsu andMcCormick, 1999; Shtutman et al., 1999).
To study the possible association between Wnt/β-catenin signaling
and cD1 expression, we used the BAT-gal reporter mouse line that
expresses LacZ under the control of the transcription factor Tcf/Lef
binding sites (Maretto et al., 2003). Upon activation of canonical Wnt
signaling, β-catenin becomes stabilized and accumulates in the
nucleus, where it binds to these transcription factors and, thus,
activates the BAT-gal reporter gene. Between E16.5 and P10, X-gal
staining revealed only limited BAT-gal reporter activity in the cochlear
duct, including the organ of Corti (Figs. 7a, b). This staining did not
parallel with cD1 expression in the embryonic cochlear duct (compare
Fig. 7a with Figs. 6c–e) or with transient cD1 expression in cochlear
HCs early postnatally (compare Fig. 7b with Fig. 4g). At the same
stages, vestibular organs showed more pronounced BAT-gal reporter
expression, especially in the nonsensory regions (Figs. 7c–e). The
utricular (Figs. 7c–e) and saccular (data not shown) sensory epithelia
showed restricted X-gal staining, while the ampullary sensory
epithelium (Fig. 7c) was strongly positive. In all these locations,
transgene expression decreased along maturation (Figs. 7a–e).
Similarly as in the cochlea, in vestibular organs no correlation was
found between BAT-gal activity and distribution of Ki-67-positive
(Fig. 7d) or cD1-positive (Fig. 7e) cells.
To directly study the possibility that cD1 is a downstream target of
β-catenin signaling, cochlear cultures from P0mice were treated with
a speciﬁc GSK-3 inhibitor, BIO (Meijer et al., 2003), for 48 h. Parallel
control explants were treated with the vehicle, DMSO, only. GSK-3 is
a critical regulator of β-catenin activity. In the absence ofWnts, GSK-3
phosphorylates β-catenin and directs it to proteosomal degradation.
In the presence of Wnts, GSK-3 is inactivated (phosphorylated),
leading to nuclear accumulation of β-catenin and transcriptional
activation of target genes (Clevers, 2006). In control cochleas, β-
catenin staining was seen in cellular junctions, as expected (Figs. 7f,
g). In BIO-treated explants, this staining was clearly stronger and was
also seen in the cell nuclei, including HC nuclei, as conﬁrmed by
staining adjacent sections for myosin 7a (Figs. 7h, i). cD1 upregulation
was not seen in HCs in cultures supplemented with BIO (Figs. 7j–l).
Likewise, BIO-treated organ of Corti did not show Ki-67 induction
(Fig. 7l′). We conclude from these experiments that cD1 is not a
target of Wnt/β-catenin signaling in the neonatal cochlear sensory
epithelium.
Discussion
In the current work, we show that several members of the Cki
family are found in the inner ear HCs and supporting cells during
development and maturation. Expression of these negative cell cycle
regulators becomes more restricted along maturation, in that only
two of them, p19Ink4d in HCs and p27Kip1 in supporting cells, are clearly
detected during adulthood. The presence of Ckis in HCs and
supporting cells is consistent with the postmitotic status of these
cells. We also show that cD1 is expressed in a dynamic pattern in the
inner ear sensory epithelia. Importantly, the transient cD1 expression
in cochlear HCs during early postnatal life parallels with the
spatiotemporal pattern of abnormal proliferation of these cells
when the Ckis p19Ink4d and p21Cip1 are simultaneously inactivated
(Laine et al., 2007). These expression data together with our
experimental data in vitro demonstrate that, in addition to presence
of Ckis, suppression of cD1 expression underlies the maintenance of
the postmitotic state of the inner ear sensory epithelial cells.
Current results show that p19Ink4d is the predominant Cki both in
cochlear and vestibular HCs. p19Ink4d was not expressed in precursorcells of the embryonic sensory epithelia, but was induced in HCs at the
onset of differentiation. This is consistent with earlier data showing
p19Ink4d expression in the late-embryonic organ of Corti (Chen et al.,
2003). Although p19Ink4d levels decreased along maturation, its
expression was clearly detected in adult HCs. p19Ink4d was coex-
pressed with p21Cip1 in HCs during development and maturation, in
line with earlier data showing that the intensity of abnormal
proliferation of cochlear HCs is signiﬁcantly enhanced by the
compound p19Ink4d/p21Cip1 inactivation as compared to the single
p19Ink4d inactivation (Chen et al., 2003; Laine et al., 2007). Our data
show that also p57Kip2 is expressed in cochlear OHCs and very weakly
in a subset of IHCs at late-embryogenesis and around birth
(Kirjavainen et al, 2008; present study), indicative of its collaborative
role in the regulation of the postmitotic state of developing HCs. In
addition, p57Kip2 might have additional functions that are indepen-
dent of its role in cell cycle suppression (Yan et al., 1997; Zhang et al.,
1998; Dyer and Cepko, 2000; Kirjavainen et al., 2008). Further
evidence for the role of p57Kip2 as a negative cell cycle regulator comes
from the data showing that the timing of suppression of its expression
in cochlear OHCs, at P3, parallels with the stage at which these cells
from the p19Ink4d/p21Cip1 dko mice show ﬁrst signs of unscheduled
DNA replication (Laine et al., 2007).
However, Cki expressions alone do not explain the pattern of cell
cycle reactivation in HCs from the p19Ink4d/p21Cip1 dko mice. This
abnormal proliferation is restricted to the ﬁrst and second postnatal
weeks and it follows a gradient from the base to the middle region of
the cochlear duct (Laine et al., 2007). Cki expressions did not follow
this kind of gradient. Even more strikingly, p19Ink4d and p21Cip1 are
expressed both in cochlear and vestibular HCs, but their codeletion
affects the cell cycle status of cochlear HCs only (Laine et al., 2007).
Further, despite the prominent p19Ink4d expression in cochlear HCs
during adulthood (present study), p19Ink4d single inactivation (similar
to p19Ink4d/p21Cip1 compound inactivation) does not trigger cell cycle
reactivation of adult HCs (Chen et al., 2003; Laine et al., 2007). These
data imply that HC's quiescence is regulated by additional
mechanisms.
The current study provides the ﬁrst evidence of the role of cD1 in
cell cycle regulation the inner ear. cD1 was transiently upregulated in
cochlear HCs during the ﬁrst 2 postnatal weeks and its expression
paralleled with abnormal HC proliferation seen in the cochleas from
the p19Ink4d/p21Cip1 dko mice. The fact that cD1 expression was not
found in the mature cochlear HCs is consistent with the data that
these cells from the adult p19Ink4d/p21Cip1 dko mice do not re-enter
the cell cycle. Further, the absence of cD1 frommost of vestibular HCs
correlates with the nonproliferative status of these cells in the
p19Ink4d/p21Cip1 dko mice throughout life. Direct functional evidence
for the role of cD1 came from our experiments in which cD1 was
misexpressed in utricular HCs in explant cultures. These cells from the
p19Ink4d/p21Cip1 dko, but not from wildtype mice showed abnormal S-
phase re-entry. Thus, our results show that the ability of HCs to re-
enter the cell cycle is regulated at the level of Cdk4/6 by cD1, which
promotes progression through G1, and by Ckis that counteract the
positive action of cyclins. It is interesting that cD1 is transiently
expressed in cochlear HCs early postnatally, during the period of
functional maturation. This is a so-called sensitive period when
cochlear HCs are hypersensitive to environmental traumas. This
hypersensitivity applies particularly to HCs located in cochlear regions
where cD1 is expressed (reviewed in Henley and Rybak, 1995). cD1 is
upregulated in traumatized neurons and has been suggested to have a
proapoptotic role in these cells, a role that is not necessarily connected
with unscheduled DNA replication (Ino and Chiba, 2001; Yang and
Herrup, 2007). In addition to traumatized neurons, cD1 is expressed in
several neuronal populations of the normal brain, this basal
expression being most prominent in hippocampal neurons that
comprise an exceptionally vulnerable neuronal population (Koeller
et al., 2008). Combining these data to the current results, basal cD1
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sensory cell populations and developmental/maturation periods that
are associated with hypersensitivity to exogenous stresses. However,
the possible direct involvement of cD1 in promoting apoptosis of
these cells remains to be shown.
Our results demonstrate that, during embryogenesis, the onset of
morphological differentiation of cochlear and vestibular HCs is
associated with cD1 downregulation. In contrast, surrounding
supporting cells continued to express cD1 after the onset differenti-
ation, with the exception of Deiter's cells, the supporting cell type
surrounding cochlear HCs. These results suggest that the role of Ckis in
counteracting the proliferation-promoting activity of cD1 is crucial for
the maintenance of the postmitotic state of most types of inner ear
supporting cells. Interestingly, during the neonatal period, cells in the
utricular supporting cell layer showed low-level DNA replication
despite p27Kip1 expression. However, this p27Kip1 expression was
weak. Thus, in the neonatal utricle, high cD1 levels seem to override
the inhibitory effect of Ckis. Mitogens stimulate transcription and
translation of D-type cyclins during G1-phase, promoting their
assembly with the catalytic partners, Cdk4/6, required for G1-to-S-
phase progression (Matsushime et al., 1991). The capacity of
vestibular supporting cells to proliferate has been shown in the rat
utricular explants maintained in serum-containing medium. It was
shown that this proliferative capacity is largely restricted to neonatal
period and that it steeply declines thereafter. It was further shown
that exogenous neuregulin and insulin are potent triggers of DNA
replication in these cells (Montcouquiol and Corwin, 2001a,b; Gu et
al., 2007; Lu and Corwin, 2008). Interestingly, the decrease in
proliferation capacity of the rat utricular supporting cells occurs
between P4 and P7 (Lu and Corwin, 2008), a period that parallels with
cD1 downregulation in these cells from the mouse, as shown in the
current study. Taken together, in utricular supporting cells, the
growth-promoting action of exogenous mitogens seems to be
mediated by cD1 and the proliferative response of these cells is
tightly linked to the pattern of basal cD1 expression. Thus, cD1
expression is critical for the proliferative capacity of utricular
supporting cells.
In themature utricle, cD1 expressionwasmaintained in a subset of
supporting cells, in addition that a small number of HCs seemed to
express this protein. Utricular supporting cells of adult mammals have
been shown to proliferate in vitro in response to ototoxic trauma that
destroys surrounding HCs (Warchol et al., 1993) and in response to
exogenous mitogens (Gu et al., 2007; Lu and Corwin, 2008). However,
this proliferative activity in adults is very low as compared to the
robust proliferation in response to exogenous mitogens during early
postnatal life (Montcouquiol and Corwin, 2001a,b; Gu et al., 2007; Lu
and Corwin, 2008). Despite cD1 expression in a subset of supporting
cells of adult utricles, it is possible that the levels of Cdk4/6, the
catalytic partners of the complex with cD1, limit the growth-
promoting effect of mitogens. Connected to this, the maintained
expression of p27Kip1 may set an inhibitory threshold that active cD1/
Cdk complexes cannot override.
Our suggestion that the dynamic expression cD1 underlies
proliferative capacity of utricular supporting cells can be extended
to cochlear supporting cells. White et al. (2006) showed that
supporting cells puriﬁed from the neonatal mouse cochlea and
maintained in vitro can re-enter the cell cycle and that this event is
associated with p27Kip1 downregulation. It was also shown that
proliferative capacity of these cells is largely restricted to early
postnatal stages. These data correlate well with our results demon-
strating distinct cD1 expression in several types of cochlear support-
ing cells early postnatally and its downregulation thereafter.
Expression of cD1 had almost completely disappeared from the
adult organ of Corti. These results reﬂect the big challenges in the
development of novel methods aimed to stimulate cochlear HC
regeneration. For effective therapeutic regeneration, it is likely thatsupporting cell-to-HC transdifferentiation needs to be preceded by
supporting cell divisions. Based on the current study, stimulation of
cD1 expression in a targeted manner might be a way to therapeuti-
cally trigger divisions of mature supporting cells.
Of the growth factors, Wnt family proteins have been implicated as
positive regulators of cell proliferation, although they have several
other functions, such as promotion of differentiation (reviewed in
Clevers, 2006). β-catenin, the intracellular mediator ofWnts, interacts
with transcription factors of the Tcf/Lef family. One of the many
targets of these factors is cD1 (Shtutman et al., 1999; Tetsu and
McCormick, 1999). Using the BAT-gal reporter mice, we found only
restricted activity of Wnt/β-catenin signaling in the inner ear sensory
epithelia, as analyzed from E16.5 onward. Similar transgene expres-
sion pattern was seen using the TOP-gal reporter mice (DasGupta and
Fuchs, 1999), although in our experiments the BAT-gal reporter was
more sensitive (unpublished data, U.P, H.L). BAT-gal reporter
expression did not correlate with either proliferative activity, as
assessed by Ki-67 staining, or with cD1 expression. Thus, Wnt/β-
catenin signaling appears not to be a major regulator of cD1
expression in the postnatal inner ear sensory epithelia in vivo. This
can be also concluded from our in vitro data showing that cD1 is not
upregulated in the organ of Corti of neonatal cochleas treated with the
GSK-3 inhibitor BIO. It has been recently shown in explant cultures of
the rat utricle that pharmacological inhibition of GSK-3 activity
promotes DNA synthesis of early postnatal supporting cells and that
this response declines along maturation (Lu and Corwin, 2008). The
fact that we did not see Ki-67 induction in the neonatal organ of Corti
treated with BIO suggests for differences in the mechanisms
underlying proliferative plasticity of cells of the 2 types of inner ear
sensory epithelia. This might be linked with the differential
abundance of negative cell cycle regulators of the Cki family in
these epithelia. In conclusion, considering the possibility that cD1 is a
suitable target for proliferative regeneration in the inner ear,
identiﬁcation of its upstream regulators would be worth future
investigations.
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